Atherosclerosis is accelerated in patients with long-term well-controlled Systemic Lupus Erythematosus (SLE)

Manzi, 1997, Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study, Am J Epidemiol, 145, 408, 10.1093/oxfordjournals.aje.a009122 Esdaile, 2001, Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus, Arthritis Rheum, 44, 2331, 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I Petri, 1992, Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices, Medicine, 71, 291, 10.1097/00005792-199209000-00004 Bhatt, 2006, Atherosclerosis in Asian Indians with systemic lupus erythematosus, Scand J Rheumatol, 35, 128, 10.1080/03009740600557256 Fukumoto, 1987, Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy, Acta Pathol Jpn, 37, 1 Bruce, 2005, 'Not only…but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus, Rheumatology (Oxford), 44, 1492, 10.1093/rheumatology/kei142 Mok, 1999, Do flares of systemic lupus erythematosus decline after menopause?, Scand J Rheumatol, 28, 357, 10.1080/03009749950155346 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter], Arthritis Rheum, 40, 1725, 10.1002/art.1780400928 Bombardier, 1992, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, Arthritis Rheum, 35, 630, 10.1002/art.1780350606 Friedewald, 1972, Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499 Nakajima, 1994, A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay, J Atheroscler Thromb, 1, 30, 10.5551/jat1994.1.30 Kinoshita, 2005, Determination of apolipoprotein B-48 in serum by a sandwich ELISA, Clin Chim Acta, 351, 115, 10.1016/j.cccn.2004.08.008 Hayashi, 2004, Ankle brachial pressure index and carotid intima-media thickness as atherosclerosis markers in Japanese diabetics, Diabetes Res Clin Pract, 66, 269, 10.1016/j.diabres.2004.03.013 Yambe, 2004, Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI), Biomed Pharmacother, 58, S95, 10.1016/S0753-3322(04)80015-5 Petri, 2004, The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort, Thromb Res, 114, 593, 10.1016/j.thromres.2004.07.012 Cederholm, 2005, Decreased binding of annexin V to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus, Arterioscler Thromb Vasc Biol, 25, 198, 10.1161/01.ATV.0000150415.18759.36 Lopez, 2006, Oxidized low-density lipoprotein and β2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis, Lupus, 15, 80, 10.1191/0961203306lu2267oa de Leeuw, 2006, Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus, Lupus, 15, 675, 10.1177/0961203306069972 El-Magadmi, 2004, Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women, Circulation, 110, 399, 10.1161/01.CIR.0000136807.78534.50 Jiménez, 2005, Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome, Rheumatology (Oxford), 44, 756, 10.1093/rheumatology/keh581 Selzer, 2004, Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus, Arthritis Rheum, 50, 151, 10.1002/art.11418 Sanchez-Guerrero, 2001, Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus, Am J Med, 111, 464, 10.1016/S0002-9343(01)00885-3 Svenungsson, 2003, Increased triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythematosus, Arthritis Rheum, 48, 2533, 10.1002/art.11264 Moulin, 1992, Increased concentration of plasma cholesteryl ester transfer protein in nephritic syndrome: role in dyslipidemia, J Lipid Res, 33, 1817, 10.1016/S0022-2275(20)41339-2 Yamada, 2001, Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis, Ann Rheum Dis, 60, 124, 10.1136/ard.60.2.124 Yamada, 1999, Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness, Clin Chem Lab Med, 37, 381, 10.1515/CCLM.1999.063 Shimojima, 2005, Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica, Intern Med, 44, 1009, 10.2169/internalmedicine.44.1009 Buyukhatipoglu, 2007, Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: the role of chlamydia and cytomegalovirus infection, Nephrology, 12, 25, 10.1111/j.1440-1797.2006.00742.x Badolato, 1994, Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes, J Exp Med, 180, 203, 10.1084/jem.180.1.203 Ogasawara, 2004, A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease, Atherosclerosis, 174, 349, 10.1016/j.atherosclerosis.2004.01.030 Cohn, 1999, Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins, Arterioscler Thromb Vasc Biol, 19, 2474, 10.1161/01.ATV.19.10.2474 Kugiyama, 1999, Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease, Circulation, 99, 2858, 10.1161/01.CIR.99.22.2858 Gianturco, 1982, Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages, J Clin Invest, 70, 168, 10.1172/JCI110590 Ossewaarde, 2003, Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial, Eur J Clin Invest, 33, 376, 10.1046/j.1365-2362.2003.01163.x Ohnishi, 2002, Relationship between insulin-resistance and remnant-like particle cholesterol, Atherosclerosis, 164, 167, 10.1016/S0021-9150(02)00057-6 Beisiegel, 1991, Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein, Proc Natl Acad Sci U S A, 88, 8342, 10.1073/pnas.88.19.8342 Midtvedt, 2004, Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal, J Am Soc Nephrol, 15, 3233, 10.1097/01.ASN.0000145435.80005.1E Reaven, 1974, Ultrastructural and physiological evidence for corticosteroid-induced alterations in hepatic production of very low density lipoprotein particles, J Lipid Res, 15, 74, 10.1016/S0022-2275(20)36835-8